Menu Close

Articles on Intellectual property

Displaying 1 - 20 of 104 articles

Anita Anand, Canada’s minister of public services and procurement, opens a box with some of the first 500,000 of the two million AstraZeneca COVID-19 vaccine doses that Canada secured last March through a deal with the Serum Institute of India. THE CANADIAN PRESS/Carlos Osorio - POOL

Canada is virtue signalling while waffling on global access to COVID-19 vaccines

Despite some public virtue signalling, the Canadian government is not doing all it can to improve global access to COVID-19 vaccines. Canada has yet to announce its position on the WTO patent waiver.
The US has agreed to ‘free the vaccine’, but will it work? Allison Bailey / Alamy Stock Photo

US-backed vaccine patent waiver: pros and cons explained

It's not clear whether the TRIPS agreement is what's getting in the way of vaccine supply, and waiving intellectual property rights may stifle future innovation.
Prime Minister Justin Trudeau, right, speaks with scientist Krishnaraj Tiwari at the National Research Council of Canada (NRC) Royalmount Human Health Therapeutics Research Centre facility in Montreal, Aug 31, 2020. THE CANADIAN PRESS/Graham Hughes

How Canada can become a global leader in health innovation during the COVID-19 pandemic and beyond

To continue the fast-paced collaborative research and innovation we have seen during the pandemic, here are five ways universities can support health research that responds to societal needs.
A medic administers a COVID-19 vaccine in Mumbai. India and South Africa have led efforts to get a waiver on intellectual property rights. Pratik Chorge/Hindustan Times via Getty Images

Intellectual property and COVID-19 medicines: why a WTO waiver may not be enough

A waiver may not allow all developing countries to secure medicines and other anti-COVID technologies in a timely way.
The TRIPS waiver enables WTO member states to manufacture and distribute COVID-19 drugs and medical supplies that would normally be protected by patents. (Pixabay)

COVID-19 drug and vaccine patents are putting profit before people

The TRIPS waiver makes COVID-19 treatments more accessible globally by enabling manufacture and distribution of COVID-19 drugs and medical supplies that would normally be protected by patents.

Top contributors

More